BAT Retreats, PMI Pushes Forward: How Divergent Corporate Strategies Are Reshaping South Korea's $2.3B Vaping Market

Published: August 19, 2026 • Category: Industry Analysis • Reading time: 12 min

The South Korean vaping market is witnessing a fascinating case study in corporate strategy divergence. As the country implements new nicotine regulations, two global tobacco giants are making dramatically different investment decisions that could reshape the competitive landscape of Asia’s most sophisticated vaping market. British American Tobacco (BAT) is reassessing its position, while Philip Morris International (PMI) is aggressively expanding its VEEV presence.

BAT’s Calculated Retreat: Regulatory Challenges vs. Market Reality

British American Tobacco’s position in South Korea represents a classic corporate dilemma: how to compete in a market where regulatory enforcement creates an uneven playing field. BAT Rothmans, the company’s Korean subsidiary, acknowledged on August 10, 2026, that it had previously considered withdrawing from the South Korean vaping market due to competitive pressure from unregulated products.

The statement followed a South Korean media report that interpreted BAT’s broader withdrawal from selected Vapour markets as a full exit from the country. BAT’s CEO Tadeu Marroco had previously noted that some Asian markets lack appropriate regulation or enforcement, making it difficult for regulated companies to compete against illegal products and generate sustainable financial returns.

“We have been monitoring the market since South Korea introduced new nicotine regulation and will continue assessing the sustainability of its Vapour business.”
— BAT Rothmans Statement, August 10, 2026

The APMEA Vapour Decline: Numbers Tell the Story

BAT’s strategic reassessment comes against a backdrop of declining performance in the Asia-Pacific, Middle East and Africa (APMEA) region. In the first half of 2026, BAT’s Vapour volume in APMEA fell 20.2% year on year. Revenue declined 25.6% at reported exchange rates and 28.2% at constant currency.

BAT APMEA Performance H1 2026	Year-on-Year Change	Strategic Implication
Vapour Volume	-20.2%	Market share erosion in key segments
Reported Revenue	-25.6%	Currency headwinds + volume decline
Constant Currency Revenue	-28.2%	Underlying business deterioration
Resource Allocation	Selective Exit	Focus on sustainable returns

The numbers reveal a company grappling with the economics of regulated competition in markets with weak enforcement. BAT’s public results materials did not explicitly identify South Korea as a completed market exit, suggesting a more nuanced approach than a simple withdrawal.

PMI’s Bold Expansion: VEEV inPRIME Targets 14,000 Locations

While BAT reassesses, Philip Morris International is making a substantial commitment to the South Korean market. PMI officially introduced VEEV inPRIME in June 2026, with distribution expanding to around 14,000 convenience stores and other retail channels from July.

The VEEV inPRIME launch represents PMI’s confidence in the South Korean market’s potential under the new regulatory framework. The company’s aggressive distribution strategy targets the premium segment of the vaping market, positioning VEEV as a quality alternative to both premium cigarettes and unregulated vaping products.

PMI’s Global Smoke-Free Momentum

PMI’s South Korean expansion fits within a broader global strategy centered on smoke-free products. In the second quarter of 2026, the company’s smoke-free shipments grew 7.5%, with products such as IQOS and ZYN making up about 42% of total revenue.

PMI Q2 2026 Performance	Results	Growth Driver
Net Revenue	$11.2 billion (+10.4%)	Smoke-free product growth
Adjusted Diluted EPS	$2.20 (+15.2%)	Margin expansion
Smoke-free Shipment Growth	+7.5%	IQOS, VEEV, ZYN expansion
Smoke-free Revenue Share	42%	Portfolio transformation

The Regulatory Catalyst: South Korea’s Evolving Framework

Both companies’ strategic decisions are being shaped by South Korea’s evolving nicotine regulatory framework. The new regulations create a more structured market environment, but also introduce compliance requirements that affect different companies differently.

For PMI, the regulatory clarity creates opportunities to leverage its established compliance infrastructure and premium brand positioning. For BAT, the same regulations may not fully address the competitive challenges from unregulated products that initially prompted the exit consideration.

Market Structure Implications

The divergent strategies highlight how the same regulatory environment can create different investment signals for different companies. PMI’s willingness to expand suggests confidence that the regulatory framework will create sustainable competitive advantages for compliant, premium products. BAT’s reassessment suggests more cautious expectations about the market’s ability to deliver adequate returns under current enforcement conditions.

“The contrasting moves highlight differing investment strategies as South Korea’s regulated vaping market evolves.”
— Industry Analysis, August 2026

Competitive Landscape: Regulated vs. Unregulated Dynamics

The core challenge for both companies is competing in a market where unregulated products have established significant market presence. South Korea’s vaping market, valued at approximately $2.3 billion in 2026, includes substantial segments served by products that may not fully comply with emerging regulatory standards.

South Korea Vaping Market Segments	Market Share	Regulatory Status	Growth Trend
Premium Regulated (PMI, BAT)	35-40%	Full compliance	Growing slowly
Mid-Range Compliant	25-30%	Partial compliance	Stable
Unregulated/Gray Market	30-35%	Non-compliant	Declining with enforcement
Traditional Tobacco	Declining	Established regulation	Long-term decline

Strategic Positioning Analysis

PMI’s VEEV inPRIME targets the premium regulated segment, betting that increasing enforcement will push consumers toward compliant products. The 14,000-location distribution network suggests confidence in premium pricing and brand-driven demand.

BAT’s reassessment may reflect a more conservative view of how quickly enforcement will reshape market dynamics. The company’s experience in other Asian markets where regulation hasn’t translated into competitive advantage for regulated products could inform this caution.

Supply Chain and Export Implications

The strategic divergence between BAT and PMI has significant implications for the global vaping supply chain, particularly for manufacturers and exporters. Companies that supply components, finished products, or raw materials to the South Korean market must navigate these shifting corporate strategies.

For Chinese manufacturers exporting to South Korea, the different approaches create both risks and opportunities. PMI’s expansion suggests continued demand for high-quality, compliant products and components. BAT’s caution may signal potential shifts in order volumes and supplier relationships.

Export Market Considerations

• Quality standards: Both companies require suppliers to meet strict compliance standards
• Volume predictability: PMI expansion offers more predictable demand than BAT reassessment
• Pricing pressure: Premium positioning may support better pricing than volume-driven competition
• Regulatory alignment: Suppliers must align with evolving South Korean requirements

Financial Performance and Market Valuation

The strategic decisions are reflected in the companies’ financial performance and market valuations. PMI’s stock performance reflects investor confidence in its smoke-free transformation, while BAT’s results highlight the challenges of global portfolio optimization.

Company Financial Comparison	PMI (August 2026)	BAT (H1 2026)	Market Implication
Stock Price	$187.62	£28.45	PMI premium valuation
P/E Ratio	27.0x	12.5x	Growth vs. value divergence
Smoke-free Revenue Share	42%	35%	Portfolio transformation pace
Dividend Yield	3.2%	6.8%	Income vs. growth positioning

Investor Perspective on Strategic Choices

PMI’s higher valuation reflects investor confidence in its aggressive smoke-free expansion strategy, including moves like the South Korean VEEV launch. BAT’s lower valuation incorporates both its higher dividend yield and more cautious approach to market expansion.

“Philip Morris International’s aggressive expansion into South Korea contrasts sharply with BAT’s more cautious reassessment, highlighting different risk appetites in the global vaping market.”
— Market Analysis, August 2026

Future Outlook: Regulatory Evolution and Market Maturation

South Korea’s vaping market is at a critical juncture. The regulatory framework continues to evolve, and both companies’ strategies will be tested against actual enforcement patterns and consumer behavior changes. Several key developments will shape the competitive landscape:

Short-term Projections (6-12 Months)

In the near term, PMI’s expansion will likely gain market share in the premium regulated segment. The 14,000-location distribution advantage creates significant retail presence that competitors will struggle to match quickly. BAT’s reassessment period may result in maintenance of existing market position rather than aggressive growth.

Long-term Strategic Implications (2-5 Years)

The longer-term outcome depends heavily on regulatory enforcement. If South Korea successfully reduces the unregulated segment through enforcement, PMI’s early investment in premium distribution could prove prescient. If enforcement remains weak, BAT’s caution may be validated.

For the global vaping industry, South Korea represents a test case for how regulatory frameworks interact with corporate strategy. The divergent approaches of two industry leaders create valuable insights for market participants, investors, and policymakers worldwide.

Conclusion: Divergent Paths, Common Challenges

The contrasting strategies of BAT and PMI in South Korea reveal fundamental differences in how global tobacco companies approach market challenges. PMI’s aggressive expansion with VEEV inPRIME represents confidence in premium, regulated products. BAT’s reassessment reflects caution about competitive dynamics in markets with weak enforcement.

Both approaches carry significant risks and opportunities. For industry observers, South Korea offers a real-time case study in strategic decision-making under regulatory uncertainty. For market participants, the divergent strategies create both competitive threats and partnership opportunities.

As South Korea’s regulatory framework continues to evolve, the ultimate success of these different strategies will become clearer. What’s certain is that the outcome will influence corporate strategy decisions in vaping markets across Asia and beyond.